Rephine is our GMP and regulatory
partner for this plant, as well as for future
businesses in initial phases
Client Testimonial
About this Case Study
For a young biotech company with just six employees, launching a new automated manufacturing plant was an exciting step forward. It was also a major regulatory challenge. With limited internal GMP experience, the company needed to achieve EU GMP compliance without slowing daily operations or delaying authorisation.
Rephine supported the client from early facility design through to qualification and validation, designing a practical Quality Management System suited to a small, highly automated organisation. The focus was on embedding GMP requirements into everyday operations in a way that felt manageable and sustainable for a lean team.
By combining technical expertise with close collaboration and knowledge transfer, Rephine helped the client move confidently from start up to authorised manufacturer.
Key outcomes included:
- EU GMP authorisation for the new manufacturing facility
- A right sized QMS aligned to the realities of a small organisation
- Successful audit outcomes and improved regulatory confidence
- Increased business credibility and growth opportunities
- GMP knowledge embedded across operational teams
✅ Download the full case study to discover:
- How small biotech companies can achieve GMP compliance with limited resources
- How early GMP input supports smoother facility qualification and validation
- How practical consultancy accelerates readiness without over complexity
Result: A compliant, authorised manufacturing operation supported by a scalable QMS and a trusted GMP partner.
Download the Case Study
View other our other resources and company news
Case Study GMP Consultancy for a New Manufacturing Plant
With only a small team and a highly automated process, this biotech company needed to achieve EU GMP compliance fast. This case study shows how ...
Read More
Article Why Quality Can No Longer Live in Silos
Discover why siloed quality management is no longer sustainable in life sciences. Learn how integrating audits, advisory services and digital quality systems supports continuous GxP ...
Read More
Article Why Most QMS Implementations Fail to Deliver Long-Term Value
Implementing a QMS is more than deploying software. Learn why most QMS implementations fall short, and what successful life sciences teams do differently to achieve ...
Read More
Case Study Driving Global QMS Harmonisation for a Pharmaceutical Company
This case study outlines how Rephine helped a global pharmaceutical group implement and validate a harmonised Quality Management System across more than seventy sites. It ...
Read More
Guide How to Structure MDR Technical Documentation (Annex II & III). A Practical Compliance Guide
This white paper provides a practical guide to structuring MDR Technical Documentation under Annex II and Annex III. It explains how to organise evidence, maintain ...
Read More
Blog IT Quality Assurance in Regulated Life Sciences: Key Insights
IT Quality Assurance is pivotal in regulated life sciences. From CSV and data integrity to change control and audit readiness, discover how IT QA ensures ...
Read More
General Practical compliance and inspection readiness for UK pharmaceutical quality systems
Explore how UK pharmaceutical and biotech organisations can stay prepared for MHRA, EMA and FDA inspections. This session provides expert guidance on inspection trends, compliance ...
Read More
Case Study Supporting Verification and Validation of a Medical Device Software (MDSW)
Discover how a medical device start‑up successfully verified and validated its new Medical Device Software in line with MDR requirements. With Rephine’s structured approach to ...
Read More
CSV Practical Guide to the EMA’s Draft EU GMP Revisions
The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
